Work

Author response: Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance

Year: 2023

Type: peer-review

Source: eLife

DOI: 10.7554/elife.80328.sa2

Authors: Ean Spielvogel, Sook-Kyung Lee, Shuntai Zhou, Gordon J Lockbaum, Mina Henes, Amy Sondgeroth, Klajdi Kosovrasti, Ellen A Nalivaika, Akbar Ali, Nese Kurt Yilmaz, Celia A Schiffer, Ronald Swanstrom

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, University of Massachusetts Chan Medical School

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,500

Funders: National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Center for AIDS Research, University of North Carolina at Chapel Hill

Awards: G1079176756, G2262217435, HIV Evolution Defines Virus-Host/Drug Interactions In Viremic and Aviremic People, G311558797, G5900455136, G6714156533, G6915740730, G7011138146, G7366156696, Integration of Evolution to Avoid Resistance in Structure Based Drug Design, G9000033364, G9000240271, G9000311747, The University of North Carolina Center for AIDS Research, Cancer Center Support Grant, The Interdependency of Drug Resistance Evolution and Drug Design: HIV-1 Protease, G958207224

OpenAlex ID: W4361835927

Cites: 67

Cited by: 1

Related to: 10